MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 29, 2003--VIVUS, Inc. (Nasdaq:VVUS) today announced that the Swedish Pharmaceutical Benefits Board has approved the reimbursement of transurethral therapy ...
Oct. 21, 2005 (Montreal) — Early penile rehabilitation, particularly use of intraurethral alprostadil (MUSE), can help maintain healthy penile tissue after radical prostatectomy, allowing for improved ...
Federal regulators accepted Vivus Inc.’s potential treatment for erectile dysfunction, the Mountain View company said Thursday, moving the drug one step closer to approval by the end of April. Vivus ...
Correction to: International Journal of Impotence Research (2005) 17, 86–90. doi:10.1038/sj.ijir.3901284; published online 4 November 2004 (http://www.nature.com ...
Today, there are more treatments than ever. By David Dodge Erectile dysfunction is more common than one might think. More than half of men over 40 will experience some kind of erectile problem, and ...
Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...
Erectile dysfunction (ED) is when you have trouble achieving or keeping an erection. ED can also be an early sign of an underlying health condition. ED causes significant stress, anxiety, or ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results